True Signal’s CVS Health CVS Stock Holding History

True Signal’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$7.31M	Buy	+78,436	New	+$7.57M	5.51%	3

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

True Signal's CVS Position: Q4 2022 in Review

True Signal opened a new position in CVS Health (CVS) in Q4 2022: 78,436 shares worth $7.31M. The stake represents 5.51% of the portfolio and ranks #3 among its holdings.

2,409 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

True Signal held 78,436 shares of CVS Health worth $7.31M as of Q4 2022.
CVS Health was a new True Signal position in Q4 2022.
CVS Health made up 5.51% of True Signal's portfolio in Q4 2022, its #3 holding.
2,409 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on True Signal's 13F filing for Q4 2022, filed 26 Jan 2023.